245 results on '"El-Chami, Mikhael F."'
Search Results
2. Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trial
3. Managing superior vena cava syndrome in patients with cardiac implantable electronic device leads: Strategies and considerations
4. A leadless ventricular pacemaker providing atrioventricular synchronous pacing in the real-world setting: 12-Month results from the Micra AV post-approval registry
5. Accurate detection of lead malfunction from ECG-derived bipolar pacing stimulus amplitude
6. Outcomes of patients implanted with an atrioventricular synchronous leadless ventricular pacemaker in the Medicare population
7. Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management: A Scientific Statement From the American Heart Association
8. Safety of same-day discharge after lead extraction procedures
9. Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial
10. Septal Bipolar Ablation to Prevent Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Implantation
11. The Feasibility and Safety of Flecainide Use Among Patients With Varying Degrees of Coronary Disease
12. Ambulatory atrioventricular synchronous pacing over time using a leadless ventricular pacemaker: Primary results from the AccelAV study
13. Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval Study
14. Temporal trends of device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients with underlying kidney disease
15. Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry
16. Chronic kidney disease and transvenous cardiac implantable electronic device infection—is there an impact on healthcare utilization, costs, disease progression, and mortality?
17. Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients
18. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion
19. A Predictive Model for the Long-Term Electrical Performance of a Leadless Transcatheter Pacemaker
20. Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke
21. Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker
22. 1-Year Prospective Evaluation of Clinical Outcomes and Shocks: The Subcutaneous ICD Post Approval Study
23. Impact of omitting the intravenous heparin bolus on outcomes of leadless pacemaker implantation.
24. Outcomes of tricuspid regurgitation after lead extraction.
25. Pacing and Defibrillation Consideration in the Era of Transcatheter Tricuspid Valve Replacement.
26. Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry.
27. Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study
28. Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms
29. Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results
30. Comparison of echocardiographic and fluoroscopic sizing of the left atrial appendage prior to percutaneous closure
31. Long-term performance of a pacing lead family: A single-center experience
32. Leadless Pacemaker Implantation in Hemodialysis Patients: Experience With the Micra Transcatheter Pacemaker
33. Leadless Pacemakers
34. Complex repolarization dynamics in ex vivo human ventricles are independent of the restitution properties.
35. Long-term performance of single-connector (DF4) implantable defibrillator leads.
36. Outcomes of leadless pacemaker implantation after cardiac surgery and transcatheter structural valve interventions.
37. Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.
38. Effect of Surgical Atrial Fibrillation Ablation at the Time of Cardiac Surgery on Risk of Postoperative Pacemaker Implantation
39. Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: The PARTNER (Placement of AoRtic TraNscathetER Valves) Trial and Registry
40. How to implant leadless pacemakers and mitigate major complications.
41. Novel use of an irrigated ablation catheter to monitor real‐time hemodynamics during ablation.
42. Leadless versus transvenous single‐chamber ventricular pacemakers: 3 year follow‐up of the Micra CED study.
43. Pulmonary vein anatomy assessed by cardiac magnetic resonance imaging in patients undergoing initial atrial fibrillation ablation: implications for novel ablation technologies
44. Management of Atrial Fibrillation in Elderly Adults
45. The Design of the Understanding Outcomes with the S‐ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED)
46. Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups.
47. Correlation between AV synchrony and device collected AM‐VP sequence counter in atrioventricular synchronous leadless pacemakers: A real‐world assessment.
48. Prediction of New Onset Atrial Fibrillation After Cardiac Revascularization Surgery
49. PO-04-176 THE IMPACT OF CHRONIC KIDNEY DISEASE ON HEALTHCARE UTILIZATION AND COSTS ASSOCIATED WITH CARDIAC IMPLANTABLE ELECTRONIC DEVICE INFECTION.
50. MP-470553-008 RISING BURDEN OF STROKE AND ATRIAL FIBRILLATION RELATED MORTALITY IN THE UNITED STATES FROM 1999-2020.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.